衛信康(603676.SH):子公司藥品通過仿製藥質量和療效一致性評價
格隆匯4月22日丨衛信康(603676.SH)公佈,公司全資子公司內蒙古白醫製藥股份有限公司(簡稱“白醫製藥”)收到國家藥品監督管理局覈準簽發的門冬氨酸鉀鎂注射液《藥品補充申請批準通知書》,該藥品通過仿製藥質量和療效一致性評價。門冬氨酸鉀鎂注射液爲電解質補充藥,用於低鉀血癥,洋地黃中毒引起的心律失常(主要是室性心律失常)以及心肌炎後遺症、充血性心力衰竭、心肌梗塞的輔助治療。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.